Mark Elliott Boulding
General Counsel at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,638105,272 held (−2%) | $64.03 | $105K | +1.0% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 435105,272 held (−0%) | $64.16 | $28K | +0.8% |
| Aug 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,844106,241 held (−2%) | $72.39 | $133K | -10.6% |
| Aug 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 969105,272 held (−1%) | $72.90 | $71K | -11.2% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 313107,225 held (−0%) | $83.10 | $26K | -22.1% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 833106,392 held (−1%) | $84.41 | $70K | -23.4% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 519105,873 held (−0%) | $85.84 | $45K | -24.6% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 601105,272 held (−1%) | $86.38 | $52K | -25.1% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 387107,698 held (−0%) | $83.10 | $32K | -22.1% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,036106,662 held (−1%) | $84.41 | $87K | -23.4% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 645106,017 held (−1%) | $85.84 | $55K | -24.6% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 745105,272 held (−1%) | $86.38 | $64K | -25.1% |
| Jun 22SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6,600107,122 held (−6%) | $78.50 | $518K | -17.6% |
| Jun 22SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,850105,272 held (−2%) | $79.24 | $147K | -18.3% |
| Jun 22SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,703105,581 held (−2%) | $78.50 | $134K | -17.6% |
| Jun 22SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 309105,272 held (−0%) | $79.25 | $24K | -18.4% |
| May 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,356105,668 held (−2%) | $72.08 | $170K | -10.2% |
| May 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 456105,212 held (−0%) | $72.67 | $33K | -11.0% |
| May 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 840107,112 held (−1%) | $78.23 | $66K | -17.3% |
| May 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,900105,212 held (−2%) | $79.31 | $151K | -18.4% |
| May 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 200105,812 held (−0%) | $78.00 | $16K | -17.1% |
| May 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 600105,212 held (−1%) | $79.28 | $48K | -18.4% |
| Apr 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 822106,655 held (−1%) | $68.91 | $57K | -6.1% |
| Apr 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,443105,212 held (−1%) | $69.75 | $101K | -7.2% |
| Feb 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 588107,643 held (−1%) | $68.54 | $40K | -5.6% |
| Feb 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,629106,014 held (−2%) | $69.82 | $114K | -7.3% |
| Feb 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 212105,802 held (−0%) | $68.54 | $15K | -5.6% |
| Feb 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 590105,212 held (−1%) | $69.82 | $41K | -7.3% |
| Feb 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,811111,314 held (−2%) | $69.29 | $195K | -6.6% |
| Feb 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2111,312 held (−0%) | $70.13 | $140 | -7.7% |
| Feb 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,081108,231 held (−3%) | $69.36 | $214K | -6.7% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,482115,177 held (−2%) | $76.56 | $190K | -15.5% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 265114,912 held (−0%) | $77.07 | $20K | -16.1% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,286113,626 held (−1%) | $76.45 | $98K | -15.4% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,521112,105 held (−1%) | $77.46 | $118K | -16.5% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 686111,419 held (−1%) | $78.71 | $54K | -17.8% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 107111,312 held (−0%) | $79.52 | $9K | -18.6% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,739119,162 held (−1%) | $76.95 | $134K | -15.9% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,503117,659 held (−1%) | $77.48 | $116K | -16.5% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,638118,646 held (−1%) | $77.11 | $126K | -16.1% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 949117,697 held (−1%) | $77.91 | $74K | -17.0% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 38117,659 held (−0%) | $78.60 | $3K | -17.7% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 471117,939 held (−0%) | $77.10 | $36K | -16.1% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 269117,670 held (−0%) | $77.92 | $21K | -17.0% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 11117,659 held (−0%) | $78.98 | $869 | -18.1% |
| Jan 6SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,123122,044 held (−1%) | $74.92 | $84K | -13.6% |
| Jan 6SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,035121,009 held (−1%) | $76.10 | $79K | -15.0% |
| Jan 6SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 108120,901 held (−0%) | $76.79 | $8K | -15.7% |
| Nov 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,843104,870 held (−2%) | $75.64 | $139K | -14.5% |
| Nov 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 777104,093 held (−1%) | $76.53 | $59K | -15.5% |
| Nov 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 192103,901 held (−0%) | $77.18 | $15K | -16.2% |
| Oct 9SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,757105,519 held (−2%) | $62.89 | $110K | +2.9% |
| Oct 9SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,306104,213 held (−1%) | $63.80 | $83K | +1.4% |
| Oct 9SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 312103,901 held (−0%) | $64.97 | $20K | -0.4% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,100118,925 held (−3%) | $64.43 | $200K | +0.4% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6,124112,801 held (−5%) | $65.47 | $401K | -1.2% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7,400105,401 held (−7%) | $66.44 | $492K | -2.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,500103,901 held (−1%) | $67.15 | $101K | -3.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 536105,631 held (−1%) | $64.43 | $35K | +0.4% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 824104,807 held (−1%) | $65.73 | $54K | -1.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 906103,901 held (−1%) | $66.63 | $60K | -2.9% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 550105,616 held (−1%) | $64.44 | $35K | +0.4% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 838104,778 held (−1%) | $65.72 | $55K | -1.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 877103,901 held (−1%) | $66.67 | $58K | -3.0% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,266103,901 held (−2%) | $65.07 | $147K | -0.6% |
- Sell
General Counsel Mark Elliott Boulding sold $105K of PTCT at $64.03 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Elliott Boulding sold $28K of PTCT at $64.16 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Elliott Boulding sold $133K of PTCT at $72.39 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Elliott Boulding sold $71K of PTCT at $72.90 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Elliott Boulding sold $26K of PTCT at $83.10 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Elliott Boulding sold $70K of PTCT at $84.41 — pre-scheduled 10b5-1 plan sale.